GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
EBITDA Margin
26.51%
TTM · Period ending:
GSK EBITDA Margin
Latest reported26.51%period ending
Latest reported26.51%period ending
GSK TTM EBITDA Margin (44.20% → 26.51%)
TTM ebitda margin
High-resolution chart · PNG
GSK ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 34.7417% | |
| 34.0411% | |
| 36.0805% | |
| 2.3021% | |
| 11.4282% | |
| 8.9155% | |
| 18.6712% | |
| 23.6844% | |
| 21.6605% | |
| 21.35% | |
| 20.5582% | |
| 18.8174% | |
| 18.2393% | |
| 34.9236% | |
| 35.8563% | |
| 45.8672% | |
| 48.5243% | |
| 48.9308% | |
| 49.3495% | |
| 100% | |
| 33.2926% | |
| 28.6178% | |
| 23.4282% | |
| 23.4703% | |
| 39.0271% | |
| 38.2428% | |
| 35.8425% | |
| 33.1097% | |
| 41.0595% | |
| 40.9478% | |
| 37.789% | |
| 32.3195% | |
| 40.3506% | |
| 34.5188% | |
| 32.751% | |
| 35.0055% | |
| 52.4751% | |
| 48.5594% | |
| 43.939% | |
| 37.4676% | |
| 38.3501% | |
| 38.1707% | |
| 38.8998% | |
| 39.0613% | |
| 49.8978% | |
| 46.3626% | |
| 42.5425% | |
| 39.2941% | |
| 49.5267% | |
| 47.2914% | |
| 44.9198% | |
| 43.1703% | |
| 49.2472% | |
| 48.8035% | |
| 48.2482% | |
| 45.9366% | |
| 51.2001% | |
| 48.4742% | |
| 46.3913% | |
| 44.1986% |